Participated · Seed · Oct 2022

TeamOhana provides an AI-powered headcount management platform that gives real-time visibility and a single source of truth across Finance, HR, Talent, and Hiring Managers. It connects HRIS, ATS, and finance tools into one collaborative, secure platform built with enterprise-grade access controls and workflows. The company helps teams forecast accurately, control costs, and scale with precision. Led by CEO Tushar Makhija and based in San Francisco, TeamOhana manages roughly $6B in workforce spend across 30,000+ employees. It plans to use the new funds to scale Agentic AI and launch additional products, including recruiter and sales capacity planning and a new way to manage reorgs. Previously it raised a $4M pre-seed round in October 2022, bringing total funding above $11.5M. TeamOhana is a San Francisco, CA–based provider of a strategic headcount management platform led by CEO Tushar Makhija. The platform syncs historically siloed systems to become a single source for company people planning and collaboration. Finance and people leaders receive real-time visibility into existing hiring plans and headcount forecasts to make decisions that affect product roadmaps, sales targets, and revenue projections. The company raised $4M in Seed funding and intends to use the proceeds to scale its product and its go-to-market team. Alongside the financing, TeamOhana is launching a real-time headcount analytics feature that consolidates data into a single customizable dashboard to show current and forecasted headcount. The product is positioned to empower cross-functional teams to execute strategic hiring plans on time and within budget.

Participated · Series B · Aug 2022

Arine operates an AI-driven medication optimization platform that delivers scalable, personalized medication therapy recommendations to health plans and risk-bearing providers. The platform leverages large, diverse datasets to identify the right individuals, recommend effective interventions, and continuously measure impact. Arine reports outcomes including >10% total cost savings and >40% reduction in hospitalizations, and it experienced >100% growth last year with average contract expansion of 80% with existing clients. The company focuses on improving medication safety, adherence, and effectiveness across populations, including underserved communities. With new funding, Arine plans to expand specialty pharmacy management, accelerate AI innovation to automate high-volume, low-complexity tasks, and integrate additional data to further personalize medication therapy. Arine is a medication intelligence startup that uses its platform to help health plans reduce medication errors, avoid complications, and keep patients out of the hospital. The company serves health plans and risk-bearing providers by improving medication safety and lowering cost of care. Founded in 2017 and based in San Francisco, Arine provides technology to enable better clinical and financial outcomes around medications. Arine plans to use the new funding to advance its platform capabilities to enable value-based care at scale. It intends to expand offerings beyond health plans and providers to other channel partners across the value-based care continuum. The company raised the financing as a mix of equity and debt to support that product and market expansion. Arine is an AI-driven platform that optimizes medication management for health plans and providers. The platform intakes clinical, social, and behavioral data and uses thousands of algorithms to recommend just-in-time clinical interventions for each patient. Those timely interventions are intended to reduce the total cost of care and drive a significant ROI, and the company states it saves one in every six healthcare dollars spent. Arine currently actively manages 5.5M lives. The company plans to use new funding to rapidly scale its team and its technology platform. Its product enables clinicians to provide personalized care by creating a whole picture of each patient based on multi-source data.

Participated · Equity · Jun 2021

Zipline builds and operates autonomous fixed-wing drone systems to deliver packages, with a track record of medical supply deliveries in Africa and expanding consumer deliveries in the U.S. Its commercial roster includes partners such as Walmart and more than a dozen restaurant brands including Panera, Chipotle, and Wendy’s. The company operates across four continents and has completed about two million deliveries to date. Financially, Zipline closed an extended $800 million Series H earlier this year and was most recently valued at $7.6 billion. Under its new strategic partnership with Uber, Zipline will integrate with Uber Eats and begin deliveries in existing U.S. markets later this year, aiming to scale rapidly toward a target of one million daily deliveries by 2029. The deal is intended to accelerate mainstream adoption by pairing Zipline’s infrastructure and regulatory approvals in select markets with Uber’s on-demand marketplace.

Participated · Series A · Apr 2021

Carta Healthcare provides an AI-powered platform that automates clinical data abstraction and analytics, combining machine learning with deep clinical expertise to extract and structure both structured and unstructured clinical data. Its technology generates actionable insights for health systems and life sciences organizations, streamlining data abstraction processes and reducing labor costs. The company plans to expand its customer footprint—particularly in the life sciences market—and to scale product deployment and operations following its late-2024 acquisition of Realyze Intelligence from UPMC Enterprises. The Realyze Intelligence acquisition added capabilities for rapidly analyzing data and identifying patients who match clinical trials and research studies. Founded in 2017 and headquartered in San Francisco, Carta reports consistent year-over-year growth and says the new capital will support hiring, infrastructure, and expanded market demand. The company’s CFO described Carta as financially healthy and positioned to strengthen its balance sheet and capture market opportunity. Carta Healthcare delivers collection, analysis, and insights into clinical data by providing registry data abstraction, reporting, and analytics to leading health systems. The company combines state-of-the-art technology with a team of experienced clinicians to produce high-quality registry data and associated analytics. By transforming the abstraction process and implementing powerful analytic capabilities, Carta informs data-driven decisions that can improve patient outcomes, reduce data-processing costs, and enable clinicians to spend more time on patient care. The company reports markedly faster data collection, superior data quality, and considerable cost savings for healthcare providers. Carta intends to use the recent funding to scale operations and accelerate product development to make more products accessible to more health systems. The business is focused on enhancing healthcare data processes and analytics to support better patient outcomes and research capabilities. Carta Healthcare provides AI-driven clinical data abstraction technology and services that use natural language processing and machine learning to reduce manual labor in curating trustworthy, actionable datasets. Its platform collects, analyzes, and layers analytic capabilities on clinical data to fuel data-driven healthcare decisions and improve patient care. The company supports the healthcare data registry market by transforming previously manual abstraction processes into automated workflows. Carta plans to use new funding to expand its clinical and technical teams and build new partnerships to make healthcare data more actionable. The company emphasizes making data-driven improvements to care delivery and bringing its solutions to new partners. Carta was founded in 2017 and is headquartered in San Francisco; it announced a recent Series A to accelerate growth.

Participated · Series A · Sep 2019

Flowcast provides AI-driven credit and collections solutions, leveraging patented machine-learning methodologies to build predictive risk models for financial institutions. Its platform helps lenders assess risk, automatically optimize credit offerings, and continually manage changing risk across portfolios. In 2020 Flowcast launched Tillful, a consumer-facing product that uses the same core technology to offer fast, free, transparent credit scores and access to credit for U.S. small and midsize businesses. The company announced an additional $3M investment from ING and is also backed by BitRock Capital and Katalyst Ventures. Alongside the financing it announced a pilot of a platform to help global financial institutions predict borrowers likely to fall behind and take preventive measures. Flowcast was founded in 2015 by CEO Ken So and is based in San Francisco, CA. Flowcast provides enterprise-grade machine learning solutions that power smart credit decisions for Global 500 corporations, financial institutions, logistics companies, and insurance providers. Its API-based machine learning platform leverages alternative data to unlock credit at scale and enable lenders and corporations to extend and monitor credit that conventional scoring methods miss. Led by CEO Ken So, the company targets large enterprises and global lenders. Flowcast intends to use the funds to accelerate its go-to-market strategy, support global market expansion, and further product development and improvement. The company is based in San Francisco and also maintains an Asia Pacific office in Singapore.